ITGR חוב לטווח קצר להון עצמי Integer

Strict FDA requirements and patent protection for complex orthopedic and cardiology components create significant barriers to entry for competitors. Serving as a primary valuation tool, this chart on GURU.Markets captures the metric at 0.04. Due to its unique battery certifications, Integer Holdings (ITGR) has become a critical partner for medtech behemoths and is currently expanding production capacities for neuromodulation systems and pacemakers.

This indicator measures the company's reliance on obligations maturing within one year relative to its equity, highlighting risks of sudden liquidity shortages. By analyzing this chart of short-term liabilities as a share of capital, an investor assesses the resilience of Integer Holdings (ITGR) to geopolitical shocks, which could restrict revenue through component supply chain disruptions and hinder the prompt servicing of current debts.